Abstract

Tranexamic acid has been shown to be an effective agent in reducing blood loss in various surgical procedures; however, there is a dearth of evidence for its use and potential side effects in urological surgical procedures. This review discusses the pathophysiology of tranexamic acid, its use in traumatic and surgical bleeding and the current evidence for its potential utilisation in urological surgery.

Keywords: Tranexamic acid, Anti-fibrinolytic, Blood loss, Transfusion rate, Urological surgery, Surgical bleeding.
Fulltext HTML PDF ePub
1800
1801
1802
1803
1804